Syndax to host ash investor event in person and via webcast on december 9, 2024

Waltham, mass. , nov. 5, 2024 /prnewswire/ -- syndax pharmaceuticals (nasdaq: sndx), a commercial-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced that the company will host an in-person investor event, along with a live webcast, on monday, december 9, 2024, at 7:00 a.m.
ASH Ratings Summary
ASH Quant Ranking